Huma Therapeutics, a healthcare technology company that provides AI-powered digital health solutions and patient monitoring systems, has secured $80 million in series D funding to accelerate the adoption of digital tech solutions in healthcare and research. Co-founded in 2011 by Dan Vahdat, and Rich Khatib, Huma has raised $300 million to date. The just-completed series The new $80 million capital will support Huma Therapeutics digital health platforms and fuel the company's growth.
read more..